These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 17272247)
21. Current use of low molecular weight heparins. Donayre CE Semin Vasc Surg; 1996 Dec; 9(4):362-71. PubMed ID: 8958613 [No Abstract] [Full Text] [Related]
22. Low-molecular-weight heparin in outpatient treatment of DVT. Yeager BF; Matheny SC Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716 [TBL] [Abstract][Full Text] [Related]
23. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs. Bagge L; Borowiec JW; Thelin S; Hultman J Scand Cardiovasc J; 1997; 31(5):275-81. PubMed ID: 9406294 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of low-molecular-weight and unfractioned heparin in horses. Monreal L; Villatoro AJ; Monreal M; Espada Y; Anglés AM; Ruiz-Gopegui R Am J Vet Res; 1995 Oct; 56(10):1281-5. PubMed ID: 8928943 [TBL] [Abstract][Full Text] [Related]
25. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients. Shore-Lesserson L; Reich DL; DePerio M Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020 [TBL] [Abstract][Full Text] [Related]
27. [New medical anticoagulants]. Choussat R; Montalescot G Rev Mal Respir; 1999 Nov; 16(5 Pt 2):985-95. PubMed ID: 10907447 [TBL] [Abstract][Full Text] [Related]
28. Mode of action of heparin and related drugs. Hemker HC; Beguin S Semin Thromb Hemost; 1991; 17 Suppl 1():29-34. PubMed ID: 1648791 [No Abstract] [Full Text] [Related]
29. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?]. Roĭtman EV; Dement'eva II; Meshcheriakov AV Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253 [No Abstract] [Full Text] [Related]
30. Low-molecular-weight heparins: beyond thrombosis in the management of the cancer patient. Kakkar AK Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():13-5. PubMed ID: 14730473 [TBL] [Abstract][Full Text] [Related]
31. [Effects of aprotinin on heparinized whole blood activated clotting time and whole blood prothrombin time]. Wen Z; Zhu F; He X; Xiong S; He S Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):304-6. PubMed ID: 9868081 [TBL] [Abstract][Full Text] [Related]
32. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs. Bagge L; Borowiec JW; Thelin S; Hultman J Scand Cardiovasc J; 1997; 31(6):275-81. PubMed ID: 9498931 [TBL] [Abstract][Full Text] [Related]
33. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2. Sacher R Semin Hematol; 1995 Oct; 32(4 Suppl 2):67-71. PubMed ID: 8821213 [No Abstract] [Full Text] [Related]
34. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021 [TBL] [Abstract][Full Text] [Related]
35. Fragmin (LMWH) vs heparin for anticoagulation during in vitro recycling of human blood in cardiopulmonary bypass circuits: dose-dependence and mechanisms of clotting. Bagge L; Holmer E; Wahlberg T; Nyström SO; Tydén H Blood Coagul Fibrinolysis; 1994 Apr; 5(2):273-80. PubMed ID: 8054461 [TBL] [Abstract][Full Text] [Related]
36. Protamine dosing--the quandary continues. Hall RI Can J Anaesth; 1998 Jan; 45(1):1-5. PubMed ID: 9466018 [No Abstract] [Full Text] [Related]